美国大力发展转基因生物技术,在成本—效益基础上理性考量,实施宽松型标签粘贴制度。文章以转基因安全的检测技术为切入点、阐明美国实行该政策的生物基础,并剖析了该制度背后的利益导向以及风险考量,进而建立起现行标签制度与监管制度的有机联系,此外,呈现了关于美国非强制性标签制度的社会争议,通过全方面、多角度的思考及分析旨在为转基因标签制度以及转基因技术的发展带来启示。 The United States vigorously develops biotechnology to make rational use of the genetically modified organisms on a cost-benefit basis and implements a loose labeling system. The article takes the detection technology of genetically-safe as an entry point, clarifies the biological foundation of the United States in implementing this policy, analyzes the interest orientation and risk considerations behind the system, and then establishes the organic connection between the current labeling system and the regulatory system. In addition, The social controversy on the non-mandatory labeling system in the United States aims to bring enlightenment to the development of the GMO labeling system and genetically modified technology through all-dimensional and multi-perspective thinking and analysis.